跳至主要内容
临床试验/ACTRN12613001191785
ACTRN12613001191785招募中4 期

A Pilot, Randomised, Blinded, Feasibility, Safety and Biochemical and Physiological Efficacy Study of Terlipressin versus Placebo in Hypotensive Sepsis

Anaesthesia Intensive Care Trust Fund0 个研究点目标入组 40 人开始时间: 2013年10月30日最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients aged 18 years or older
  • - Confirmed or suspected sepsis
  • presentation to the emergency department (ED) or activation of an urgent medical emergency team review or admission to the intensive care unit
  • Hypotension

排除标准

  • - Pregnancy
  • - Death is considered imminent (within 24 hours)
  • - Known contraindications to terlipressin such as: severe peripheral vascular disease, Raynaud's phenomenon, Known allergy to terlipressin, Unstable angina, Recent myocardial infarction, Asthma.

研究者

发起方
Anaesthesia Intensive Care Trust Fund

相似试验